Skip to main content
Clinical Trials/IRCT20221202056687N1
IRCT20221202056687N1
Recruiting
未知

Effects of Application of Pulsed Electromagnetic Field and Therapeutic Exercise on Bone Mineral Density and Metabolism, and Quality of Life in Postmenopausal Osteoporotic Women

Tehran University of Medical Sciences0 sites36 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
36
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • women at the age of 55\-68, having reached menopause at least 5 year before the study.
  • A body mass index of 22\-30
  • T\-score for the hip or lumbar spine \-2\.5 SD or less.
  • do not have a history of overioectomy syrgery
  • Do not have a history of osteoporosis fracture

Exclusion Criteria

  • Participating in sports regularly for at least one year before starting the study (regular exercise means at least 30 minutes a day and 3 days a week)
  • Taking drugs that affect bone metabolism, except for daily calcium and vitamin D and weekly alendronite tablets, which will be prescribed by the rheumatology consultant of the study with the same dose for all participants.
  • The presence of any medical problem affecting the person's movement (diabetes \- diseases of the vestibular system \- uncorrected vision or hearing disorders \- neurological diseases
  • A history of surgery in the spine and pelvis and the use of tools to fix it or a history of surgery in the lower limbs
  • History of hormone therapy in the last 6 months
  • A history of having cardiovascular diseases, such as uncontrolled blood pressure, which will be considered as an exclusion criterion for groups that will do exercise therapy
  • Using physiotherapy modalities effective on bone metabolism, such as using WBV, LPL, PEMF modalities in the last 6 month
  • Using tranquilizers (Tranquillizer) in both minor classifications (anti\-anxiety, diazepam, oxazepam, alprazolam, etc.) and major (antipsychotic drugs such as haloperidol, phenotazines, fluphenazine, etc.) in three last month
  • Unwillingness of the samples to continue the treatment and not participating regularly in the treatment program
  • A change in sample conditions that would result in missing one of the inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials